Long-term follow-up after a switch to bictegravir, emtricitabine, tenofovir alafenamide (B/F/TAF) from a boosted protease inhibitor-based regimen

被引：0
|
作者：
Rockstroh, J. [1 ]
Molina, J. M. [2 ]
Post, F. [3 ]
Fox, J. [4 ]
Koenig, E. [5 ]
Daar, E. S. [6 ]
Ruane, P. [7 ]
Crofoot, G. [8 ]
Oguchi, G. [9 ]
Creticos, C. [10 ]
Liu, A. [11 ]
Andreatta, K. [11 ]
Graham, H. [11 ]
Brainard, D. [11 ]
Martin, H. [11 ]
机构：
[1] Univ Hosp Bonn, Bonn, Germany
[2] Hop St Louis, Paris, France
[3] Kings Coll Hosp NHS Fdn Trust, London, England
[4] Guys & St Thomas NHS Fdn Trust, London, England
[5] Inst Dominicano Estudios Virol IDEV, Santo Domingo, Dominican Rep
[6] Harbor UCLA Med Ctr, Lundquist Inst, Torrance, CA 90509 USA
[7] Ruane Clin Res Grp Inc, Los Angeles, CA USA
[8] Crofoot Res Ctr, Houston, TX USA
[9] Midland Florida Clin Res Ctr, Deland, FL USA
[10] Howard Brown Hlth Ctr, Chicago, IL USA
[11] Gilead Sci Inc, Foster City, CA USA
来源：
HIV MEDICINE | 2021年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
O005
引用
收藏
页码：5 / 5
页数：1
相关论文
共 50 条
  • [41] Switching to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in adults aged >65 or older: week 48 results from a phase 3b, open-label trial
    Maggiolo, F.
    Rizzardini, G.
    Molina, J. M.
    Pulido, F.
    DeWit, S.
    Vandekerckhove, L.
    Berenguer, J.
    D'Antoni, M.
    Blair, C.
    Chuck, S.
    Piontkowsky, D.
    Martin, H.
    McNicholl, I.
    Payne, B.
    Gallant, J.
    HIV MEDICINE, 2020, 21 : 17 - 17
  • [42] Switching to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in adults aged>65 or older: week 48 results from a phase 3b, open-label trial
    Maggiolo, F.
    Rizzardini, G.
    Molina, J-M
    Pulido, F.
    De Wit, S.
    Vandekerckhove, L.
    Berenguer, J.
    D'Antoni, M.
    Blair, C.
    Chuck, S.
    Piontkowsky, D.
    Martin, H.
    McNicholl, I.
    Haubrich, R.
    Gallant, J.
    HIV MEDICINE, 2019, 20 : 138 - 138
  • [43] Longer-term follow-up of protease inhibitor-based dual antiretroviral therapy (PIDAT) in clinical practice
    Marshall, N.
    Smith, C.
    Swaden, L.
    Johnson, M.
    HIV MEDICINE, 2014, 15 : 120 - 120
  • [44] IMPACT OF LONG- TERM TREATMENT WITH CONTINUOUS TENOFOVIR ALAFENAMIDE ( TAF) OR AFTER SWITCH FROM TENOFOVIR DISOPROXIL FUMARATE ( TDF) ON HEPATOCELLULAR CARCINOMA ( HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B ( CHB)
    Lim, Young-Suk
    Wong, Grace Lai-Hung C.
    Ahn, Sang Hoon
    Seto, Wai-Kay
    Agarwal, Kosh
    Janssen, Harry L. A.
    Pan, Calvin Q.
    Chuang, Wan Long
    Fung, Scott K.
    Shalimar
    Brunetto, Maurizia R.
    Hui, Aric Josun
    Chang, Ting-Tsung
    Lim, Seng Gee
    Abramov, Frida
    Flaherty, John F.
    Wang, Hongyuan
    Yee, Leland J.
    Kao, Jia-Horng
    Marcellin, Patrick
    Gane, Edward J.
    Buti, Maria
    HEPATOLOGY, 2023, 78 : S523 - S526
  • [45] Long-term survival and functional follow-up in patients after the arterial switch operation
    Haas, F
    Wottke, M
    Poppert, H
    Meisner, H
    ANNALS OF THORACIC SURGERY, 1999, 68 (05): : 1692 - 1697
  • [46] Long-term integrated analysis of B/F/TAF in treatment-naive adults with HIV through five years of follow-up
    Sax, Paul
    Arribas, Jose
    Orkin, Chloe
    Lazzarin, Adriano
    Pozniak, Anton
    Maggiolo, Franco
    Stellbrink, Hans-Juergen
    Yazdanpanah, Yazdan
    Acosta, Rima
    Huang, Hailin
    Baeten, Jared
    Hindman, Jason
    Grewe, Bastian
    Martin, Hal
    Wohl, David
    HIV MEDICINE, 2023, 24 : 55 - 56
  • [47] Efficacy and safety of switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from boosted protease inhibitor-based regimens in virologically suppressed adults with HIV-1:48 week results of a randomised, open-label, multicentre, phase 3, non-inferiority trial
    Daar, Eric S.
    Dejesus, Edwin
    Ruane, Peter
    Crofoot, Gordon
    Oguchi, Godson
    Creticos, Catherine
    Rockstroh, Juergen K.
    Molina, Jean-Michel
    Koenig, Ellen
    Liu, Ya-Pei
    Custodio, Joseph
    Andreatta, Kristen
    Graham, Hiba
    Cheng, Andrew
    Martin, Hal
    Quirk, Erin
    LANCET HIV, 2018, 5 (07): : E347 - E356
  • [48] RELAPSE AFTER LONG-TERM FOLLOW-UP OF MULTIBACILLARY PATIENTS TREATED BY WHO MULTIDRUG REGIMEN
    JAMET, P
    JI, BH
    BLANC, L
    BOBIN, P
    DAUMERIE, D
    DISCAMPS, G
    FAYE, OC
    GROSSET, J
    GROSSETETE, G
    HUSSER, JA
    JAMET, P
    JI, BH
    MAHE, A
    NEBOUT, M
    PATTYN, S
    SOW, S
    TRAORE, I
    INTERNATIONAL JOURNAL OF LEPROSY, 1995, 63 (02) : 195 - 201
  • [49] RELAPSE AFTER LONG-TERM FOLLOW-UP OF MULTIBACILLARY PATIENTS TREATED BY WHO MULTIDRUG REGIMEN
    JAMET, P
    JI, BH
    INTERNATIONAL JOURNAL OF LEPROSY, 1994, 62 (04) : 622 - 622
  • [50] LONG-TERM FOLLOW-UP AFTER HEMISPHEROTOMY FROM THE PATIENTS' PERSPECTIVE
    Verdinelli, C.
    Olsson, I
    Edelvik, A.
    Flink, R.
    Hallbook, T.
    Rydenhag, B.
    Malmgren, K.
    EPILEPSIA, 2014, 55 : 177 - 177
12345